GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Gtc Biotherapeutics Inc (GTCB) [hlAlert]

GTC Biotherapeutics, Inc. is engaged in the development and production of human therapeutic proteins through transgenic technology that enables animals to produce a recombinant form of a specified human protein in their milk. Using this technology, the Company is developing a portfolio of
recombinant blood proteins to treat a range of genetic and acquired blood deficiencies, including hemophilia and other blood coagulation disorders. These blood proteins, also known as plasma proteins, are difficult to produce in other manufacturing systems, and some are only available by extraction from human blood. It has also initiated the development of a portfolio of monoclonal antibodies (MAb?s), for use as potential follow-on biologics targeted at several market products. Its first product ATryn, its recombinant form of human antithrombin, a blood protein with anticoagulation and anti-inflammatory properties.
.
( Total: 1 Current Stock Recommendations )
Gtc Biotherapeutics Inc   (1)
Buy 100%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  


* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy